Body Mass Index Genetic Risk Score and Endometrial Cancer Risk.

Autor: Prescott J; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America., Setiawan VW; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America., Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Schumacher F; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America., Yu H; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America.; Department of Epidemiology and Public Health, Yale Cancer Center, Yale School of Public Health, New Haven, Connecticut, United States of America., Delahanty R; Division of Epidemiology, Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America., Bernstein L; Beckman Research Institute, City of Hope, Duarte, California, United States of America., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Chen C; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center and Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, United States of America., Cook LS; University of New Mexico, Albuquerque, New Mexico, United States of America., Friedenreich C; Division of Cancer Care, Department of Population Health Research, Alberta Health Services-Cancer Control Alberta, Calgary, Alberta, Canada., Garcia-Closas M; Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom., Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America., Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America., Liang X; Memorial Sloan Kettering Cancer Center, New York, New York, United States of America., Lissowska J; Department of Epidemiology and Cancer Prevention, Cancer Center and M Sklodowska-Curie Institute of Oncology, Warsaw, Poland., Lu L; Department of Epidemiology and Public Health, Yale Cancer Center, Yale School of Public Health, New Haven, Connecticut, United States of America., Magliocco AM; H. Lee Moffitt Cancer Centre, Tampa, Florida, United States of America., Olson SH; Memorial Sloan Kettering Cancer Center, New York, New York, United States of America., Risch HA; Department of Epidemiology and Public Health, Yale Cancer Center, Yale School of Public Health, New Haven, Connecticut, United States of America., Shu XO; Division of Epidemiology, Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America., Ursin G; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.; Cancer Registry of Norway, Oslo, Norway.; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway., Yang HP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Kraft P; Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America., De Vivo I; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2015 Nov 25; Vol. 10 (11), pp. e0143256. Date of Electronic Publication: 2015 Nov 25 (Print Publication: 2015).
DOI: 10.1371/journal.pone.0143256
Abstrakt: Genome-wide association studies (GWAS) have identified common variants that predispose individuals to a higher body mass index (BMI), an independent risk factor for endometrial cancer. Composite genotype risk scores (GRS) based on the joint effect of published BMI risk loci were used to explore whether endometrial cancer shares a genetic background with obesity. Genotype and risk factor data were available on 3,376 endometrial cancer case and 3,867 control participants of European ancestry from the Epidemiology of Endometrial Cancer Consortium GWAS. A BMI GRS was calculated by summing the number of BMI risk alleles at 97 independent loci. For exploratory analyses, additional GRSs were based on subsets of risk loci within putative etiologic BMI pathways. The BMI GRS was statistically significantly associated with endometrial cancer risk (P = 0.002). For every 10 BMI risk alleles a woman had a 13% increased endometrial cancer risk (95% CI: 4%, 22%). However, after adjusting for BMI, the BMI GRS was no longer associated with risk (per 10 BMI risk alleles OR = 0.99, 95% CI: 0.91, 1.07; P = 0.78). Heterogeneity by BMI did not reach statistical significance (P = 0.06), and no effect modification was noted by age, GWAS Stage, study design or between studies (P≥0.58). In exploratory analyses, the GRS defined by variants at loci containing monogenic obesity syndrome genes was associated with reduced endometrial cancer risk independent of BMI (per BMI risk allele OR = 0.92, 95% CI: 0.88, 0.96; P = 2.1 x 10-5). Possessing a large number of BMI risk alleles does not increase endometrial cancer risk above that conferred by excess body weight among women of European descent. Thus, the GRS based on all current established BMI loci does not provide added value independent of BMI. Future studies are required to validate the unexpected observed relation between monogenic obesity syndrome genetic variants and endometrial cancer risk.
Databáze: MEDLINE
Externí odkaz: